Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 989.75 INR
Change Today -22.15 / -2.19%
Volume 1.3M
As of 7:05 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Rajesh V. Desai

Chief Financial Officer and Executive Director, Glenmark Pharmaceuticals Ltd.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Rajesh V. Desai serves as the Chief Financial Officer of Glenmark Pharmaceuticals Ltd. Mr. Desai has over 26 years experience in the pharmaceutical industry. He joined GPL in 1983 and previously employed with Progressive Business Consultants Private Limited. He served as Director for IT, Legal & Finance of Glenmark Pharmaceuticals Ltd. Mr. Desai has been the Non-Executive Director at Glenmark Generics Ltd. since August 14, 2009. Mr. Desai has been an Executive Director ...

Read Full Background

Corporate Headquarters*

Glenmark House
Mumbai, Maharashtra 400099


Phone: 91 22 4018 9999
Fax: 91 22 4018 9990

Board Members Memberships*

Chief Financial Officer and Executive Director


Unknown/Other Education
University of Mumbai
Unknown/Other Education
Institute of Chartered Accountants of India

Other Affiliations*

Annual Compensation*

Total Annual Compensation16,259,169

Stock Options*

All Other Compensation17,112,497

Total Compensation*

Total Annual Cash Compensation33,371,666
Total Short Term Compensation16,259,169
Other Long Term Compensation17,112,497
Total Calculated Compensation33,371,666
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNP:IN 989.75 INR -22.15


George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
Pankaj R. Patel M.PharmChairman, Managing Director, Chairman of Share Transfer Committee, Chairman of Committee of Directors, Chairman of Corporate Social Responsibility Committee, Chairman of Risk Management Committee and Member of Investors'/ Stakeholders' Relationship Committee
Cadila Healthcare Limited
Arthur S. Przybyl Chief Executive Officer, President and Director
ANI Pharmaceuticals, Inc.
Arthur P. Bedrosian J.D.Chief Executive Officer, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
Hari Shankar Bhartia B.TechCo-Chairman, Managing Director, Chairman of Corporate Governance Committee, Member of Compensation Committee, Member of Fund Raising Committee, Member of Finance Committee and Member of Sustainability & CSR Committee
Jubilant Life Sciences Limited
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLENMARK PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at